Schedule 13G ownership disclosure

AVEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 053588307

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,568,355
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-21-006793
Form type
SC 13G
Filer
AVEO PHARMACEUTICALS, INC.
CIK
CIK 1325879
Filed
Feb 02, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub